Green Park & Golf Ventures
VC Fund
Dallas, United States
Green Park & Golf Ventures is a VC fund in Dallas focused on Health Care and Medical. Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
- Total investments:
- 94
- Last investment:
- Lead investor:
- 13%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Green Park & Golf Ventures invests in
Stages Green Park & Golf Ventures invests in
Countries Green Park & Golf Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $420k–$3.2M
- Series A
- $1.3M–$18M
- Series B
- $2.1M–$45M
Investment Focus
Industry
- Health Care 37 (39%)
- Medical 23 (24%)
- Biotechnology 19 (20%)
- Medical Device 15 (16%)
- Software 14 (15%)
Stage
- Series A 23 (24%)
- Seed 21 (22%)
- Series B 12 (13%)
- Funding Round 10 (11%)
- Series C 5 (5%)
Country
- United States 61 (65%)
- Israel 1 (1%)
- Sweden 1 (1%)
- Germany 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
JR Garcia
Principal & VP of Investments
|
Principal & VP of Investments | Total investments: 1 | Find email | |
Carl Soderstrom
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
Claire England
Investment Partner
|
Investment Partner | Total investments: 12 | Find email | |
Clay Heighten
Founding Member
|
Founding Member | Total investments: 2 | Find email | |
|
Dan Parsley
Managing Partner
|
Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vellum Health
|
Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients. | Series A / Jun 26, 2025 | |
Mobia Medical
|
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas. | $65M / Series F / Mar 12, 2025 | |
Affineon Health
|
Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow. | $5M / Seed / Feb 03, 2025 | |
Prolocor
|
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA. | $1.7M / Convertible Note / Feb 27, 2024 | |
Worlds
|
Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before. | $21.2M / Series A / Jan 03, 2023 | |
Validic
|
Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina. | $12M / Venture - Series Unknown / Nov 14, 2022 | |
|
Prolocor
|
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA. | $3.2M / Seed / Aug 16, 2022 | |
|
Mobia Medical
|
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas. | $73M / Series E / Jun 20, 2022 | |
Genomenon
|
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants fromgenomic-sequencing datasets.It was founded in 2014 and is headquartered in Ann Arbor, Michigan. | $20M / Series B / Mar 08, 2022 | |
Alto
|
Alto provides on-demand rides using a dedicated fleet of new, safe, and well-maintained vehicles. Each driver is an employee of Alto and is carefully vetted and trained to give members a professional and predictable ride, every time. Alto's elegant apps and in-car technology customize each member's experience each time. In short, membersdrive everything, except for the car. The company is launching in Dallas, Texas with plans to scale to new US cities in 2019. Alto was founded in 2018 and is headquartered in Dallas, Texas, United States | $45M / Series B / Jun 28, 2021 | |
| See all 94 investments → | |||
Co-Investors
Capital Factory
3 deals together
IrishAngels
3 deals together
Tech Wildcatters
3 deals together
UT Horizon Fund
3 deals together
Action Potential Venture Capital
2 deals together
Align Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Green Park & Golf Ventures invest in?
Green Park & Golf Ventures invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 94 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Green Park & Golf Ventures's check size?
Green Park & Golf Ventures typically joins rounds of $420k–$3.2M at Seed, $1.3M–$18M at Series A and $2.1M–$45M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Green Park & Golf Ventures participates in.
How do I contact Green Park & Golf Ventures?
Public channels for Green Park & Golf Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Green Park & Golf Ventures?
The team at Green Park & Golf Ventures includes JR Garcia (Principal & VP of Investments), Carl Soderstrom (Founding Partner) and Claire England (Investment Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
